X-LINKED PROTOPORPHYRIA (XLP)

Clinical trials for X-LINKED PROTOPORPHYRIA (XLP) explained in plain language.

Never miss a new study

Get alerted when new X-LINKED PROTOPORPHYRIA (XLP) trials appear

Sign up with your email to follow new studies for X-LINKED PROTOPORPHYRIA (XLP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New pill aims to let patients step into the sun without pain

Symptom relief Ongoing

This study is testing whether an investigational drug called MT-7117 can help people with rare light-sensitive skin disorders (EPP or XLP) spend more time in sunlight before feeling painful burning or itching. About 165 participants, aged 12 to 75, will take either the drug or a …

Matched conditions: X-LINKED PROTOPORPHYRIA (XLP)

Phase: PHASE3 • Sponsor: Tanabe Pharma America, Inc. • Aim: Symptom relief

Last updated Mar 30, 2026 14:33 UTC

X-LINKED PROTOPORPHYRIA (XLP)

Get alerted when new X-LINKED PROTOPORPHYRIA (XLP) trials appear

New pill aims to let patients step into the sun without pain